文献速递主动脉疾病

临床衰弱评分可预测开窗与分支主动脉修复术后胸腹主动脉瘤患者的远期生存与功能状态恢复

Clinical frailty predicts long-term survival and return to functional status following fenestrated and branched aortic repair for thoracoabdominal aortic aneurysm.
PubMed 文献 · J Vasc Surg · 2025-03-12

本研究基于2012至2023年前瞻性医生发起的研究性器械豁免临床试验,纳入213例接受开窗与分支腔内修复(F/BEVAR)的胸腹主动脉瘤(TAAA)患者,其中标准风险96例(45%)、高风险117例(55%)。多变量分析显示较高临床衰弱评分(CFS)与远期生存降低相关(HR 1.37,95%CI 1.07-1.74),标准风险患者恢复术前功能状态的比例更高(92.7% vs 68.4%,P<.01)。作者认为直接测量表型衰弱可用于F/BEVAR术前风险分层与患者选择。

要点

  • 较高CFS与F/BEVAR术后远期生存降低独立相关(HR 1.37,95%CI 1.07-1.74)。
  • 标准风险患者恢复术前功能状态比例高于高风险患者(92.7% vs 68.4%,P<.01)。
  • CFS≥4患者1年生存70% vs 90%、5年生存33% vs 53%(P=.01)。

核心结论

  • 较高CFS患者远期生存更差且恢复术前功能状态的可能性更低,即使校正内科合并症后仍如此。
  • 作者认为识别高风险患者(包括使用临床衰弱量表直接测量表型衰弱)是F/BEVAR术前风险分层和患者选择的重要工具。

研究设计与样本

  • 前瞻性、医生发起的研究性器械豁免临床试验,纳入2012至2023年接受F/BEVAR治疗TAAA的全部患者。
  • 共213例患者,其中标准风险96例(45%)、高风险117例(55%)。
  • 高风险标准为具有以下一项或多项:CFS≥4、代谢当量≤2、既往脊髓损伤或卒中、充血性心力衰竭、需吸氧的慢性阻塞性肺疾病(COPD)、慢性肾脏病(CKD)IV或V期、外周动脉疾病、预期寿命超过1年的活动性癌症、重度主动脉粥样斑块负荷、肝硬化病史和/或物质使用障碍。
  • 采用Kaplan-Meier分析和Cox回归分析评估远期生存与恢复术前功能状态(RFS),并按CFS≥4与<4进行二次生存分析,校正年龄、性别、充血性心力衰竭、需吸氧的COPD、CKD IV/V期。

主要发现

  • 高风险队列中,CFS≥4者57例(48.7%)、CKD IV/V期者49例(41.9%)、代谢当量<2者33例(28.2%)。
  • 多变量分析中,较高CFS(HR 1.37,95%CI 1.07-1.74)、较低体重指数(HR 0.87,95%CI 0.82-0.99)、较大动脉瘤尺寸(HR 1.03,95%CI 1.01-1.05)、需吸氧的COPD(HR 2.64,95%CI 1.62-4.30)和CKD IV或V期(HR 2.85,95%CI 1.29-6.28)与远期生存降低相关。
  • 标准风险患者较高风险患者更可能恢复术前功能状态(92.7% vs 68.4%,P<.01);较高CFS(OR 0.49,95%CI 0.34-0.72)和需吸氧的COPD(OR 0.42,95%CI 0.20-0.88)与恢复术前功能状态的可能性降低相关。
  • 高风险患者1年生存率低于标准风险患者(76% vs 95%),5年生存率亦较低(39% vs 58%,P<.01)。
  • 按CFS分层后生存差异持续存在:CFS≥4患者1年生存率70% vs 90%、5年生存率33% vs 53%(P=.01)。

关键数值与推荐

  • 高风险分类标准:CFS≥4、代谢当量≤2、既往脊髓损伤或卒中、充血性心力衰竭、需吸氧的COPD、CKD IV或V期、外周动脉疾病、预期寿命超过1年的活动性癌症、重度主动脉粥样斑块负荷、肝硬化病史和/或物质使用障碍中一项或多项。
  • 较高CFS与远期生存降低相关(HR 1.37,95%CI 1.07-1.74)。
  • 较高CFS与恢复术前功能状态可能性降低相关(OR 0.49,95%CI 0.34-0.72)。
  • 标准风险患者恢复术前功能状态比例92.7% vs 高风险患者68.4%(P<.01)。
  • 高风险患者1年生存76% vs 标准风险95%,5年生存39% vs 58%(P<.01)。

临床怎么用

  • 作者认为识别高风险患者(包括使用临床衰弱量表直接测量表型衰弱)是F/BEVAR术前风险分层和患者选择的重要工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Prior studies have demonstrated that frailty, characterized by a patient's burden of chronic medical comorbidities, is predictive of adverse outcomes across surgical specialties. This study uses the clinical frailty score (CFS) to assess the impact of phenotypic frailty on long-term mortality and return to preoperative functional status (RFS) following fenestrated and branched endovascular repair (F/BEVAR) for thoracoabdominal aortic aneurysm (TAAA). METHODS: All patients enrolled in a prospective, physician-sponsored investigational device exemption clinical trial from 2012 to 2023 following F/BEVAR for TAAA were included. Patients were assigned to a standard or high-risk category, if they had one or more of the following criteria: CFS ≥4, metabolic equivalent of ≤2, prior spinal cord injury or stroke, CHF, chronic obstructive pulmonary disease (COPD) with oxygen requirement, chronic kidney disease (CKD) stage IV or V, peripheral artery disease, active cancer with life expectancy of more than 1 year, heavy aortic atheroma burden, history of cirrhosis, and/or substance use disorder. Long-term survival and RFS were assessed using Kaplan-Meier analysis and Cox regression analysis based on high-risk status. A secondary survival analysis based on CFS (CFS ≥4 and <4) was performed with adjustment for age, sex, congestive heart failure, COPD with oxygen requirement, CKD stage IV/V. RESULTS: 213 patients underwent F/BEVAR, including 96 standard-risk (45%) and 117 high-risk patients (55%). Other than high-risk classifiers, there were no differences in comorbidities, operative presentation, or maximum aneurysm diameter. Within the high-risk study cohort, a total of 57 patients had a CFS of ≥4 (48.7%), 49 patients had CKD stage IV/V (41.9%), and 33 patients had a metabolic equivalent of <2 (28.2%). Higher CFS (hazard ratio [HR], 1.37; 95% CI, 1.07-1.74), lower body mass index (HR, 0.87; 95% CI, 0.82-0.99), larger aneurysm size (HR, 1.03; 95% CI, 1.01-1.05), COPD with oxygen requirement (HR, 2.64; 95% CI, 1.62-4.30), and CKD stage IV or V (HR, 2.85; 95% CI, 1.29-6.28) were associated with reduced long-term survival in multivariable analysis. Standard-risk patients were more likely to RFS (92.7% vs 68.4%; P < .01), whereas a higher CFS (odds ratio [OR], 0.49; 95% CI, 0.34-0.72) and COPD with oxygen requirement (OR, 0.42; 95% CI, 0.20-0.88) were associated with a lower likelihood of RFS. High-risk patients had lower survival at 1 year (76% vs 95%) and 5 years (39% vs 58%; P < .01). When stratified by CFS, differences in survival persisted. Patients with CFS of ≥4 also had reduced survival at 1 year (70% vs 90%) and 5 years (33% vs 53%; P = .01), respectively. CONCLUSIONS: Patients with a higher CFS have worse long-term survival and are less likely to RFS, even after adjustment for medical comorbidities. Given these findings, the identification of high-risk patients, including direct measurement of phenotypic frailty using the clinical frailty scale is an important tool for preoperative risk stratification and patient selection for F/BEVAR.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Murphy BE, Bunker M, Gillan A, et al. Clinical frailty predicts long-term survival and return to functional status following fenestrated and branched aortic repair for thoracoabdominal aortic aneurysm. J Vasc Surg. 2025. PMID: 40086494. doi:10.1016/j.jvs.2025.03.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。